Lv5
1126 积分 2021-08-03 加入
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
6天前
已完结
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate
8天前
已完结
GPR75 mediates hyperuricemia-induced endothelial inflammatory injury via a HOTAIR/miR-141-3p regulatory network
16天前
已完结
FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance
1个月前
已完结
GPR75 knockdown alleviates mitochondrial dysfunction in retinal ganglion cells via AMPK pathway in diabetic mice
1个月前
已完结
Limonoid walrobsin A alleviates LPS-induced septic acute kidney injury through modulating inflammatory microenvironment by targeting G protein-coupled receptor 75
2个月前
已完结
Unexpected effects of semaglutide on skeletal muscle mass and force-generating capacity in mice
2个月前
已完结
Unexpected effects of semaglutide on skeletal muscle mass and force-generating capacity in mice
2个月前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
2个月前
已完结
G protein-coupled receptor 75 mediates depression-like behaviors and HPA axis hyperactivity through an excitatory arcuate-paraventricular nucleus circuit
3个月前
已完结
皖公网安备34019202002308
